Apr 8, 2016

Kaketsuken in talks to sell vaccine business to Astellas

The Chemo-Sero-Therapeutic Research Institute, or Kake-tsuken, is negotiating with major Japanese drugmaker Astellas Pharma Inc. on the sale of its vaccine and blood products manufacturing operations, informed sources said Friday. Kaketsuken, headquartered in Kumamoto, in January received a 110-day business suspension order, the longest ...

Oct 15, 2015

Heavy demand leads to mumps vaccine shortage

Vaccines for mumps are in short supply across the country due to heavier-than-expected demand, sources say. Drugmakers have started to notify medical institutions of the situation, although the shortfall is expected to be alleviated between next week and late November, the sources said. Some ...

Oct 3, 2015

Flu vaccine prices uniformly rise 50 percent in Japan

Retail prices of seasonal influenza vaccines made by four major Japanese drug makers this autumn have risen a uniform 50 percent from a year before, medical and municipal sources said Saturday. Medical institutions are concerned that the country’s influenza immunization rate may drop due ...